New approaches hurdle biological barriers to attack recalcitrant targets to tackle difficult-to-treat and recurrent cancers.

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related ...

HOUSTON, DECEMBER 4, 2025 ― At The University of Texas MD Anderson Cancer Center , research breakthroughs are made possible through seamless ...

Regular exercise and sufficient protein intake can help maintain muscle and preserve long-term health in patients taking ...

UCLA scientists have characterized the structure and function of a key survival protein in breast cancer cells that helps ...

A research team at Florida State University's Institute of Molecular Biophysics and Department of Chemistry and Biochemistry ...

A research team led by Dr. Àlex Bayés, Head of the Molecular Physiology of the Synapse Group at the Institut de Recerca Sant ...

Scientists discovered that the protein RPA plays a critical and previously unconfirmed role in stimulating telomerase to ...

Roughly a quarter of all cancerous tumors are caused by mutations in the KRAS gene, which fosters cell growth. For more than three decades, scientists believed these mutations were impervious to ...

Researchers at the Department of Cell and Molecular Biology, Karolinska Institutet have captured the first detailed molecular ...

In an effort to reveal the inner workings of a protein that serves as a cell's damage detection system, scientists at Johns Hopkins and the Ludwig-Maximilians-University Munich (LMU) have published ...